Your browser doesn't support javascript.
loading
Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia.
Balcha, Shitaye A; Demisse, Abayneh G; Mishra, Rajashree; Vartak, Tanwi; Cousminer, Diana L; Hodge, Kenyaita M; Voight, Benjamin F; Lorenz, Kim; Schwartz, Stanley; Jerram, Samuel T; Gamper, Arla; Holmes, Alice; Wilson, Hannah F; Williams, Alistair J K; Grant, Struan F A; Leslie, R David; Phillips, David I W; Trimble, Elisabeth R.
Afiliação
  • Balcha SA; Department of Internal Medicine, Gondar University Hospital, Gondar, Ethiopia.
  • Demisse AG; Department of Pediatrics and Child Health, School of Medicine, University of Gondar, Gondar, Ethiopia.
  • Mishra R; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Vartak T; Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cousminer DL; Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Hodge KM; Blizard Institute, Queen Mary University of London, London, UK.
  • Voight BF; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Lorenz K; Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Schwartz S; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Jerram ST; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Gamper A; Center for Spatial and Functional Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Holmes A; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Wilson HF; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Williams AJK; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Grant SFA; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Leslie RD; Main Line Health System, Wynnewood, PA, USA.
  • Phillips DIW; Blizard Institute, Queen Mary University of London, London, UK.
  • Trimble ER; Severn Postgraduate School of Primary Care, Health Education England, Bristol, UK.
Diabetologia ; 63(10): 2158-2168, 2020 10.
Article em En | MEDLINE | ID: mdl-32705316
ABSTRACT
AIMS/

HYPOTHESIS:

We aimed to characterise the immunogenic background of insulin-dependent diabetes in a resource-poor rural African community. The study was initiated because reports of low autoantibody prevalence and phenotypic differences from European-origin cases with type 1 diabetes have raised doubts as to the role of autoimmunity in this and similar populations.

METHODS:

A study of consecutive, unselected cases of recently diagnosed, insulin-dependent diabetes (n = 236, ≤35 years) and control participants (n = 200) was carried out in the ethnic Amhara of rural North-West Ethiopia. We assessed their demographic and socioeconomic characteristics, and measured non-fasting C-peptide, diabetes-associated autoantibodies and HLA-DRB1 alleles. Leveraging genome-wide genotyping, we performed both a principal component analysis and, given the relatively modest sample size, a provisional genome-wide association study. Type 1 diabetes genetic risk scores were calculated to compare their genetic background with known European type 1 diabetes determinants.

RESULTS:

Patients presented with stunted growth and low BMI, and were insulin sensitive; only 15.3% had diabetes onset at ≤15 years. C-peptide levels were low but not absent. With clinical diabetes onset at ≤15, 16-25 and 26-35 years, 86.1%, 59.7% and 50.0% were autoantibody positive, respectively. Most had autoantibodies to GAD (GADA) as a single antibody; the prevalence of positivity for autoantibodies to IA-2 (IA-2A) and ZnT8 (ZnT8A) was low in all age groups. Principal component analysis showed that the Amhara genomes were distinct from modern European and other African genomes. HLA-DRB1*0301 (p = 0.0014) and HLA-DRB1*04 (p = 0.0001) were positively associated with this form of diabetes, while HLA-DRB1*15 was protective (p < 0.0001). The mean type 1 diabetes genetic risk score (derived from European data) was higher in patients than control participants (p = 1.60 × 10-7). Interestingly, despite the modest sample size, autoantibody-positive patients revealed evidence of association with SNPs in the well-characterised MHC region, already known to explain half of type 1 diabetes heritability in Europeans. CONCLUSIONS/

INTERPRETATION:

The majority of patients with insulin-dependent diabetes in rural North-West Ethiopia have the immunogenetic characteristics of autoimmune type 1 diabetes. Phenotypic differences between type 1 diabetes in rural North-West Ethiopia and the industrialised world remain unexplained.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Diabetes Mellitus Tipo 1 / Transportador 8 de Zinco Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Etiópia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Diabetes Mellitus Tipo 1 / Transportador 8 de Zinco Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male País/Região como assunto: Africa Idioma: En Revista: Diabetologia Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Etiópia